
Identification of High‐Risk Chronic Heart Failure Patients in Clinical Practice: Role of Changes in Left Ventricular Function
Author(s) -
Cicoira Mariantonietta,
Rossi Andrea,
Chiampan Andrea,
Frigo Giulia,
Bergamini Corinna,
Rigolli Marzia,
Zanolla Luisa,
Vassanelli Corrado
Publication year - 2012
Publication title -
clinical cardiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.263
H-Index - 72
eISSN - 1932-8737
pISSN - 0160-9289
DOI - 10.1002/clc.22024
Subject(s) - medicine , ejection fraction , heart failure , cardiology , hazard ratio , proportional hazards model , confidence interval , etiology
Background: Left ventricular (LV) dysfunction and remodeling are key pathophysiological features underlying disease progression in chronic heart failure (CHF). Hypothesis: To describe the course of LV dysfunction and identify predictors and prognostic impact of changes in LV volumes and function in stable CHF patients under optimal therapy. Methods: There were 318 consecutive CHF outpatients who underwent a repeated echocardiographic evaluation at baseline and at 1 year and subsequently followed‐up for at least 12 months. The end point of the study was all‐cause mortality. Results: Mean LV ejection fraction (LVEF) was 33 ± 7% at baseline and 36 ± 9% at follow‐up. Twenty‐four percent of patients had an improvement of LVEF >5 absolute points (group 1); 58% remained stable (group 2), 17% worsened at >5 absolute points (group 3). Age, New York Heart Association class, diuretic dose, renal function, and baseline LVEF were independent predictors of LVEF improvement at 1 year. At the Cox analysis, patients in group 3 had a 4‐fold higher risk of death when compared with group 1 (hazard ratio: 3.99, 95% confidence interval: 1.6‐9.9, P = 0.002), independently of age, etiology, and symptoms severity. Conclusions: In stable CHF outpatients, LV function improves in 24% of cases; a modest decrease in LV systolic function is associated with a significantly higher risk of all‐cause mortality, independent of other markers of disease severity. Clin. Cardiol. 2012 doi: 10.1002/clc.22024 The authors have no funding, financial relationships, or conflicts of interest to disclose.